New Vaccines, New Administration: Why We Need a Collective Effort

New vaccines and a new White House administration are promising to finally lift us out of the crushing effects of the pandemic. Some people, however, are still questioning the safety and efficacy of vaccines that were developed so quickly.

To dispel myths and set the record straight, these five renowned thought leaders explain what factors led to the speedy development and approval of certain vaccines, provide scientific and data-driven perspectives on why they are safe, and highlight why eradicating the coronavirus must be a collective effort.

Karim Lakhani and Marco Iansiti

Global Authorities on AI-Enabled Business and Operating Models That Helped Moderna Successfully Develop Its COVID-19 Vaccine

“AI-enabled systems allowed Cambridge, Massachusetts-based Moderna to confirm its COVID-19 vaccine’s efficacy and safety, which led to the successful development of a vaccine with 94.5% efficacy levels that can remain stable at standard refrigerator temperatures,” says Harvard digital transformation architect Karim Lakhani who also focuses on breakthrough innovation experiments.

“But the reality is, contributions from all players – traditional big pharma and cutting-edge, AI-powered biotechs – will also be necessary,” adds “Competing in the Age of AI” co-author Marco Iansiti. “With a target market of 7 billion vaccine recipients, multiple COVID-19 vaccines will be needed to supply the world. Or, as Moderna CEO Stephane Bancel puts it, ‘We are confident in our vaccine, but with a view on achieving the needed scale, we are rooting for everyone.’”

Larry Brilliant, MD

Pioneering Physician, Advisor, Epidemiologist and Public Health Expert Who Helps Organizations Develop Plans for Safely Conducting Business During a Pandemic

“There is no way to stop the risk that I have or you have unless we stop the risk everywhere in the world. Bear in mind, we need a vaccination campaign in 220 countries and it has to be coordinated,” says Dr. Larry Brilliant, who was part of the team that eradicated the Smallpox virus in the 70s. “You would think a pandemic, of all things, would bring us closer together – and it may yet. But this virus will continue to go back and forth and re-infect us until we finally figure out that we are better off working together than working alone.”

Bart De Langhe

Leading Digital Marketing Scientist Who Helps Organizations Optimize Data So They Can Better Understand and Serve Customers and Markedly Drive Growth 

“The year 2020 will enter the history books as the year in which a new deadly coronavirus brought the world to a halt. Pharmaceutical companies jumped to the rescue with major investments in vaccine research and development, and in recent months one company after another released insights about the efficacy of their candidate vaccines,” marvels Esade behavioral economist and data scientist Bart De Langhe, whose AI-driven models help organizations optimize data to drive growth. “While these announcements have major implications for the world’s economy in 2021, they also provide valuable lessons for managers who want to use data to make better decisions. Data is often hailed as an antidote to the biases of human intuition, but effectively using data for decision making actually requires that we intelligently harness our intuition.”

Life Beyond COVID for Businesses, Governments and Communities

As the vaccine campaign ramps up, organizations will be making plans to rebuild, readjust and reenter an unfamiliar marketplace, well-aware that a new economy presents a new set of challenges. Organizational leaders looking for insights, frameworks and strategies for success may want to access the expertise of top thinkers who can help them achieve their goals – realizing, as Dr. Larry Brilliant says,“we are better off working together than working alone.” 

Whitney Jennings: